Duerden M, Payne R. Polypharmacy and medicines optimisation Making it safe and sound Authors. London: The Kings Fund; 2013. p. 1–68.
Hanlon JT, Artz MB, Pieper CF, et al. Inappropriate medication use among frail elderly inpatients. Ann Pharmacother. 2004;38:9–14. https://doi.org/10.1345/aph.1D313.
NICE GUIDELINE. Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes. 2015.
Hernández-Rodríguez MÁ, Sempere-Verdú E, Vicens-Caldentey C, González-Rubio F, Miguel-García F, Palop-Larrea V, et al. Evolution of polypharmacy in a spanish population (2005–2015): a database study. Pharmacoepidemiol Drug Saf. 2020;29:433–43. https://doi.org/10.1002/pds.4956.
Kojima T, Mizokami F, Akishita M. Geriatric management of older patients with multimorbidity. Geriatr Gerontol Int. 2020;20:1105–11. https://doi.org/10.1111/ggi.14065.
Bergman H, Ferrucci L, Guralnik J, Hogan DB, Hummel S, Karunananthan S, et al. Frailty: An Emerging Research and Clinical Paradigm—Issues and Controversies. J Gerontol A Biol Sci Med Sci. 2009;62:731–7. https://doi.org/10.1093/gerona/62.7.731.
Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Waite L, Seibel MJ, et al. Polypharmacy cutoff and outcomes: Five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65:989–95. https://doi.org/10.1016/j.jclinepi.2012.02.018.
Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370:173–84. https://doi.org/10.1016/S0140-6736(07)61091-5.
Scottish Government Model of Care Polypharmacy Working Group. Polypharmacy Guidance, Realistic Prescribing. 3rd ed. 2018.
Poudel A, Peel NM, Nissen LM, Mitchell CA, Gray LC, Hubbard RE. Adverse outcomes in relation to polypharmacy in robust and frail older hospital patients. J Am Med Dir Assoc. 2016;17:767.e9-767.e13. https://doi.org/10.1016/j.jamda.2016.05.017.
Yap AF, Thirumoorthy T, Kwan YH. Systematic review of the barriers affecting medication adherence in older adults. Geriatr Gerontol Int. 2016;16:1093–101. https://doi.org/10.1111/ggi.12616.
World Health Organization. Adherence to Long-Term Therapies. Evidence for action. 2003. p. 1–198.
Zazzara MB, Palmer K, Vetrano DL, Carfì A, Graziano O. Adverse drug reactions in older adults: a narrative review of the literature. Eur Geriatr Med. 2021;12:463–73. https://doi.org/10.1007/s41999-021-00481-9.
Poudel A, Peel N, Mitchell C, et al. A systematic review of prescribing criteria to evaluate appropriateness of medications in frail older people. Rev Clin Gerontol. 2014;24:304–18. https://doi.org/10.1017/S0959259814000161.
Griese-Mammen N, Hersberger KE, Messerli M, Leikola S, Horvat N, van Mil JWF, et al. PCNE definition of medication review: reaching agreement. Int J Clin Pharm. 2018;40:1199–208. https://doi.org/10.1007/s11096-018-0696-7.
Molist-Brunet N, Sevilla-Sánchez D, Puigoriol-Juvanteny E, Espaulella-Ferrer M, Amblàs-Novellas J, Espaulella-Panicot J. Factors associated with the detection of inappropriate prescriptions in older people : a prospective cohort. Int J Environ Res Public Health. 2021;18:1–17. https://doi.org/10.3390/ijerph182111310.
Thompson W, Lundby C, Graabæk T, Nielsen DS, Ryg J, Søndergaard J, et al. Tools for deprescribing in frail older persons and those with limited life expectancy: a systematic review. J Am Geriatr Soc. 2019;67:172–80. https://doi.org/10.1111/jgs.15616.
Molist Brunet N, Sevilla-Sánchez D, Amblàs Novellas J, CodinaJané C, Gómez-Batiste X, McIntosh J, et al. Optimizing drug therapy in patients with advanced dementia: a patient-centered approach. Eur Geriatr Med. 2014;5:66–71. https://doi.org/10.1016/j.eurger.2013.10.011.
Molist Brunet N, EspaulellaPanicot J, Sevilla-Sánchez D, Amblàs Novellas J, CodinaJané C, AltimirasRoset J, et al. A patient-centered prescription model assessing the appropriateness of chronic drug therapy in older patients at the end of life. Eur Geriatr Med. 2015;6:565–9. https://doi.org/10.1016/j.eurger.2015.07.008.
Molist-Brunet N, Sevilla-Sánchez D, Puigoriol-Juvanteny E, González-Bueno J, Solà- Bonada N, Cruz-Grullón M, et al. Optimizing drug therapy in frail patients with type 2 diabetes mellitus. Aging Clin Exp Res. 2020;32:1551–9. https://doi.org/10.1007/s40520-019-01342-z.
Molist-Brunet N, Sevilla-Sánchez D, González-Bueno J, Garcia-Sánchez V, Segura-Martín LA, Codina-Jané C, et al. Therapeutic optimization through goal-oriented prescription in nursing homes. Int J Clin Pharm. 2021. https://doi.org/10.1007/s11096-020-01206-x.
González-Bueno J, Sevilla-Sánchez D, Puigoriol-Juvanteny E, Molist-Brunet N, Codina-Jané C, Espaulella-Panicot J. Improving medication adherence and effective prescribing through a patient-centered prescription model in patients with multimorbidity. Eur J Clin Pharmacol. 2021. https://doi.org/10.1007/s00228-021-03207-9.
Molist-Brunet N, Sevilla-Sánchez D, Puigoriol-Juvanteny E, Bajo-Peñas L, Cantizano-Baldo I, Cabanas-Collell L, et al. Individualized medication review in older people with multimorbidity: a comparative analysis between patients living at home and in a nursing home. Int J Environ Res Public Health. 2022;19:1–13. https://doi.org/10.3390/ijerph19063423.
Boyd K, Murray SA. Recognising and managing key transitions in end of life care. BMJ. 2010;341: c4863. https://doi.org/10.1136/bmj.c4863.
Granger CV, Albretch GLH. Outcome of comprehensive medical rehabilitation: Measurement by PULSES profile and the Barthel index. Arch Phys Med Rehabil. 1979;60:145–54.
Use T. THE The Barthel ADL Index : Guidelines. 2008. p. 0–1.
Salisbury C, Johnson L, Purdy S, Valderas JM, Montgomery AA. Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract. 2011;61:12–21. https://doi.org/10.3399/bjgp11X548929.
Brusselaers N, Lagergren J. The Charlson Comorbidity Index in Registry-based Research. Methods Inf Med. 2017;6(5):401–6.
Reisberg B, Ferris S, De Leon M, Crook T. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139:1136–9.
Amblàs-Novellas J, Martori JC, Espaulella J, Oller R, Molist-Brunet N, Inzitari M, et al. Frail-VIG index: a concise frailty evaluation tool for rapid geriatric assessment. BMC Geriatr. 2018;18:29. https://doi.org/10.17863/CAM.21161.
George J, Phun Y-T, Bailey MJ, Kong DCM, Stewart K. Development and validation of the medication regimen complexity index. Ann Pharmacother. 2004;38:1369–76.
Saez de la Fuente J, SuchDiaz A, Cañamares-Orbis I, Ramila E, Izquierdo-Garcia E, Esteban C, et al. Cross-cultural adaptation and validation of the medication regimen complexity index adapted to Spanish. Ann Pharmacother. 2016;50:918–25. https://doi.org/10.1177/1060028016656385.
Hilmer S, Mager D, Simonsick E. A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 2007;167:781–7. https://doi.org/10.1001/archinte.167.8.781.
Gómez-Batiste X, Martínez-Muñoz M, Blay C, Amblàs J, Vila L, Costa X, et al. Prevalence and characteristics of patients with advanced chronic conditions in need of palliative care in the general population: A cross-sectional study. Palliat Med. 2014;28:302–11. https://doi.org/10.1177/0269216313518266.
Reuben DB, Jennings LA. Putting goal-oriented patient care into practice. J Am Geriatr Soc. 2019;67:1342–4. https://doi.org/10.1111/jgs.15885.
Lee SJ, Kim CM. Individualizing prevention for older adults. J Am Geriatr Soc. 2018;66:229–34. https://doi.org/10.1111/jgs.15216.
O’Mahony D, O’Connor MN. Pharmacotherapy at the end-of-life. Age Ageing. 2011;40:419–22. https://doi.org/10.1093/ageing/afr059.
American Diabetes Association. 12-Older adults : standards of medical care in diabetes-2021. Diabetes Care. 2021;44:S168–79. https://doi.org/10.2337/dc21-s012.
Gómez-Huelgas R, Gómez Peralta F, Rodríguez Mañas L, Formiga F, Puig Domingo M, Mediavilla Bravo JJ, et al. Treatment of type 2 diabetes mellitus in elderly patients. Rev Clínica Española. 2018;218:74–88. https://doi.org/10.1016/j.rceng.2017.12.004.
Curtin D, Gallagher P, Mahony DO. Deprescribing in older people approaching end-of-life: development and validation of STOPPFrail version 2. Age Ageing. 2021;50:465–71. https://doi.org/10.1093/ageing/afaa159.
Petersen LK, Christensen K, Kragstrup J. Lipid-lowering treatment to the end? a review of observational studies and RCTs on cholesterol and mortality in 80+-year olds. Age Ageing. 2010;39:674–80. https://doi.org/10.1093/ageing/afq129.
Van der Steen JT, Radbruch L, Hertogh CMPM, de Boer ME, Hughes JC, Larkin P, et al. White paper defining optimal palliative care in older people with dementia: a Delphi study and recommendations from the European Association for Palliative Care. Palliat Med. 2014;28:197–209. https://doi.org/10.1177/0269216313493685.
Bjerre LM, Farrell B, Hogel M, Graham L, Lemay G, McCarthy L, et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline. Can Fam Physician. 2018;64:17–27.
Fick DM, Semla TP, Steinman M, Beizer J, Brandt N, Dombrowski R, et al. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2019;67:674–94. https://doi.org/10.1111/jgs.15767.
Scottish Intercollegiate Guidelines Network, (SIGN). Management of chronic pain A national clinical guideline. 2019.
O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2014;44:213–8. https://doi.org/10.1093/ageing/afu145.
Récoché I, Lebaudy C, Cool C, Sourdet S, Piau A, Lapeyre-Mestre M, et al. Potentially inappropriate prescribing in a population of frail elderly people. Int J Clin Pharm. 2017;39:113–9. https://doi.org/10.1007/s11096-016-0406-2.
González-Bueno J, Sevilla-Sánchez D, Puigoriol-Juvanteny E, Molist-Brunet N, Codina-Jané C, Espaulella-Panicot J. Factors associated with medication non-adherence among patients with multimorbidity and polypharmacy admitted to an intermediate care center. Int J Environ Res Public Health. 2021;18:9606. https://doi.org/10.3390/ijerph18189606.
Muñoz-Ortiz L, Mompart-Penina A, Mias M. Anàlisi de les defuncions observades i esperades durant l’epidèmia de COVID-19 a Catalunya. Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS). Generalitat de Catalunya; 2020. p. 5–16.
Liew TM, Lee CS, Goh SKL, Chang ZY. The prevalence and impact of potentially inappropriate prescribing among older persons in primary care settings: Multilevel meta-analysis. Age Ageing. 2020;49:570–9. https://doi.org/10.1093/ageing/afaa057.
Herr M, Sirven N, Grondin H, Pichetti S, Sermet C. Frailty, polypharmacy, and potentially inappropriate medications in old people: findings in a representative sample of the French population. Eur J Clin Pharmacol. 2017;73:1165–72. https://doi.org/10.1007/s00228-017-2276-5.
Sallevelt BTGM, Huibers CJA, Heij JMJO, Egberts TCG, van Puijenbroek EP, Shen Z, et al. Frequency and acceptance of clinical decision support system-generated STOPP/START signals for hospitalised older patients with polypharmacy and multimorbidity. Drugs Aging. 2022;39:59–73. https://doi.org/10.1007/s40266-021-00904-z.
Liau SJ, Lalic S, Sluggett JK, Cesari M, Onder G, Vetrano DL, et al. Medication management in frail older people: consensus principles for clinical practice, research, and education. J Am Med Dir Assoc. 2021;22:43–9. https://doi.org/10.1016/j.jamda.2020.05.004.
Ouellet GM, Ouellet JA, Tinetti ME. Principle of rational prescribing and deprescribing in older adults with multiple chronic conditions. Ther Adv Drug Saf. 2018;9:639–52. https://doi.org/10.1177/2042098618791371.
Fog AF, Mdala I, Engedal K, Straand J. Variation between nursing homes in drug use and in drug-related problems. BMC Geriatr. 2020;20:1–9. https://doi.org/10.1186/s12877-020-01745-y.
Pantuzza LL, Ceccato M das GB, Silveira MR, Junqueira LMR, Reis AMM. Association between medication regimen complexity and pharmacotherapy adherence: a systematic review. Eur J Clin Pharmacol. 2017;73:1475–89. https://doi.org/10.1007/s00228-017-2315-2.
Fournier A, Anrys P, Beuscart JB, Dalleur O, Henrard S, Foulon V, et al. Use and deprescribing of potentially inappropriate medications in frail nursing home residents. Drugs Aging. 2020;37:917–24. https://doi.org/10.1007/s40266-020-00805-7.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Disclaimer:
This article is autogenerated using RSS feeds and has not been created or edited by OA JF.
Click here for Source link (https://www.biomedcentral.com/)